Cargando…
Mast cells selectively produce inflammatory mediators and impact the early response to Chlamydia reproductive tract infection
INTRODUCTION: Chlamydia trachomatis (C. trachomatis) is a Gram-negative obligate intracellular bacterium that causes reproductive tract complications in women, including ectopic pregnancies and tubal factor infertility. We hypothesized that mast cells, which are common at mucosal barriers, may contr...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10150091/ https://www.ncbi.nlm.nih.gov/pubmed/37138882 http://dx.doi.org/10.3389/fimmu.2023.1166068 |
_version_ | 1785035291619229696 |
---|---|
author | Mayavannan, Animamalar Shantz, Emily Haidl, Ian D. Wang, Jun Marshall, Jean S. |
author_facet | Mayavannan, Animamalar Shantz, Emily Haidl, Ian D. Wang, Jun Marshall, Jean S. |
author_sort | Mayavannan, Animamalar |
collection | PubMed |
description | INTRODUCTION: Chlamydia trachomatis (C. trachomatis) is a Gram-negative obligate intracellular bacterium that causes reproductive tract complications in women, including ectopic pregnancies and tubal factor infertility. We hypothesized that mast cells, which are common at mucosal barriers, may contribute to responses to Chlamydia infection and aimed to define human mast cell responses to C. trachomatis. METHODS: Human cord blood-derived mast cells (CBMCs) were exposed to C. trachomatis to assess bacterial uptake, mast cell degranulation, gene expression, and production of inflammatory mediators. The role of formyl peptide receptors and Toll-like receptor 2 (TLR2) were investigated using pharmacological inhibitors and soluble TLR2. Mast cell-deficient mice and littermate controls were used to examine the in vivo role of mast cells in influencing the immune response to Chlamydia infection in the female reproductive tract. RESULTS: C. trachomatis bacteria were taken up by human mast cells but did not replicate efficiently inside CBMCs. C. trachomatis-activated mast cells did not degranulate but maintained viability and exhibited cellular activation with homotypic aggregation and upregulation of ICAM-1. However, they significantly enhanced the gene expression of IL1B, CCL3, NFKB1, CXCL8, and IL6. Inflammatory mediators were produced, including TNF, IL-1β, IL-1RA, IL-6, GM-CSF, IL-23, CCL3, CCL5, and CXCL8. Endocytic blockade resulted in reduced gene expression of IL6, IL1B, and CCL3, suggesting C. trachomatis induced mast cell activation in both extracellular and intracellular locations. The IL-6 response to C. trachomatis was reduced when CBMCs were treated with C. trachomatis coated with soluble TLR2. Mast cells derived from TLR2-deficient mice also demonstrated a reduced IL-6 response to C. muridarum. Five days following C. muridarum infection, mast cell-deficient mice showed attenuated CXCL2 production and significantly reduced numbers of neutrophils, eosinophils, and B cells in the reproductive tract when compared with mast cell-containing littermates. DISCUSSION: Taken together, these data demonstrate that mast cells are reactive to Chlamydia spp. through multiple mechanisms that include TLR2-dependent pathways. Mast cells also play an important role in shaping in vivo immune responses in Chlamydia reproductive tract infection through both effector cell recruitment and modification of the chemokine microenvironment. |
format | Online Article Text |
id | pubmed-10150091 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-101500912023-05-02 Mast cells selectively produce inflammatory mediators and impact the early response to Chlamydia reproductive tract infection Mayavannan, Animamalar Shantz, Emily Haidl, Ian D. Wang, Jun Marshall, Jean S. Front Immunol Immunology INTRODUCTION: Chlamydia trachomatis (C. trachomatis) is a Gram-negative obligate intracellular bacterium that causes reproductive tract complications in women, including ectopic pregnancies and tubal factor infertility. We hypothesized that mast cells, which are common at mucosal barriers, may contribute to responses to Chlamydia infection and aimed to define human mast cell responses to C. trachomatis. METHODS: Human cord blood-derived mast cells (CBMCs) were exposed to C. trachomatis to assess bacterial uptake, mast cell degranulation, gene expression, and production of inflammatory mediators. The role of formyl peptide receptors and Toll-like receptor 2 (TLR2) were investigated using pharmacological inhibitors and soluble TLR2. Mast cell-deficient mice and littermate controls were used to examine the in vivo role of mast cells in influencing the immune response to Chlamydia infection in the female reproductive tract. RESULTS: C. trachomatis bacteria were taken up by human mast cells but did not replicate efficiently inside CBMCs. C. trachomatis-activated mast cells did not degranulate but maintained viability and exhibited cellular activation with homotypic aggregation and upregulation of ICAM-1. However, they significantly enhanced the gene expression of IL1B, CCL3, NFKB1, CXCL8, and IL6. Inflammatory mediators were produced, including TNF, IL-1β, IL-1RA, IL-6, GM-CSF, IL-23, CCL3, CCL5, and CXCL8. Endocytic blockade resulted in reduced gene expression of IL6, IL1B, and CCL3, suggesting C. trachomatis induced mast cell activation in both extracellular and intracellular locations. The IL-6 response to C. trachomatis was reduced when CBMCs were treated with C. trachomatis coated with soluble TLR2. Mast cells derived from TLR2-deficient mice also demonstrated a reduced IL-6 response to C. muridarum. Five days following C. muridarum infection, mast cell-deficient mice showed attenuated CXCL2 production and significantly reduced numbers of neutrophils, eosinophils, and B cells in the reproductive tract when compared with mast cell-containing littermates. DISCUSSION: Taken together, these data demonstrate that mast cells are reactive to Chlamydia spp. through multiple mechanisms that include TLR2-dependent pathways. Mast cells also play an important role in shaping in vivo immune responses in Chlamydia reproductive tract infection through both effector cell recruitment and modification of the chemokine microenvironment. Frontiers Media S.A. 2023-04-17 /pmc/articles/PMC10150091/ /pubmed/37138882 http://dx.doi.org/10.3389/fimmu.2023.1166068 Text en Copyright © 2023 Mayavannan, Shantz, Haidl, Wang and Marshall https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Mayavannan, Animamalar Shantz, Emily Haidl, Ian D. Wang, Jun Marshall, Jean S. Mast cells selectively produce inflammatory mediators and impact the early response to Chlamydia reproductive tract infection |
title | Mast cells selectively produce inflammatory mediators and impact the early response to Chlamydia reproductive tract infection |
title_full | Mast cells selectively produce inflammatory mediators and impact the early response to Chlamydia reproductive tract infection |
title_fullStr | Mast cells selectively produce inflammatory mediators and impact the early response to Chlamydia reproductive tract infection |
title_full_unstemmed | Mast cells selectively produce inflammatory mediators and impact the early response to Chlamydia reproductive tract infection |
title_short | Mast cells selectively produce inflammatory mediators and impact the early response to Chlamydia reproductive tract infection |
title_sort | mast cells selectively produce inflammatory mediators and impact the early response to chlamydia reproductive tract infection |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10150091/ https://www.ncbi.nlm.nih.gov/pubmed/37138882 http://dx.doi.org/10.3389/fimmu.2023.1166068 |
work_keys_str_mv | AT mayavannananimamalar mastcellsselectivelyproduceinflammatorymediatorsandimpacttheearlyresponsetochlamydiareproductivetractinfection AT shantzemily mastcellsselectivelyproduceinflammatorymediatorsandimpacttheearlyresponsetochlamydiareproductivetractinfection AT haidliand mastcellsselectivelyproduceinflammatorymediatorsandimpacttheearlyresponsetochlamydiareproductivetractinfection AT wangjun mastcellsselectivelyproduceinflammatorymediatorsandimpacttheearlyresponsetochlamydiareproductivetractinfection AT marshalljeans mastcellsselectivelyproduceinflammatorymediatorsandimpacttheearlyresponsetochlamydiareproductivetractinfection |